Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in 3 phase III North American studies

被引：0
|
作者：
Curry, Michael [1 ]
Vargas, Hugo E. [2 ]
Befeler, Alex [3 ]
Pyrsopoulos, Nikolaos T. [4 ]
Patwardhan, Vilas [1 ]
Jamil, Khurram [5 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Mayo Clin, Rochester, MN USA
[3] St Louis Univ, St Louis, MO USA
[4] Rutgers New Jersey Med Sch, Univ Hosp, Newark, NJ USA
[5] Mallinckrodt Pharmaceut, Staines Upon Thames, England
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI537
引用
收藏
页码：S634 / S635
页数：2
相关论文
共 50 条
  • [31] Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis in the North American population: Pooled analysis of phase III studies
    Pariser, David
    Frankel, Ellen
    Schlessinger, Joel
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB251 - AB251
  • [32] THE EFFICACY AND SAFETY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN PHASE III TRIAL
    Nitti, V
    Herschorn, S.
    Auerbach, S.
    Ayers, M.
    Lee, M.
    Martin, N.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 278 - 278
  • [33] Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
    David Pariser
    Ellen Frankel
    Joel Schlessinger
    Yves Poulin
    Ronald Vender
    Richard G. Langley
    Xiangyi Meng
    Adriana Guana
    Judit Nyirady
    Dermatology and Therapy, 2018, 8 : 17 - 32
  • [34] Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
    Pariser, David
    Frankel, Ellen
    Schlessinger, Joel
    Poulin, Yves
    Vender, Ronald
    Langley, Richard G.
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    DERMATOLOGY AND THERAPY, 2018, 8 (01) : 17 - 32
  • [35] CLINICAL AND BIOCHEMICAL-STUDIES IN 3 PATIENTS WITH SEVERE EARLY INFANTILE COCKAYNE SYNDROME
    JAEKEN, J
    KLOCKER, H
    SCHWAIGER, H
    BELLMANN, R
    HIRSCHKAUFFMANN, M
    SCHWEIGER, M
    HUMAN GENETICS, 1989, 83 (04) : 339 - 346
  • [36] A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasis
    Spelman, Lynda
    Rubel, Diana
    Brnabic, Alan
    Burkhardt, Nicole
    Riedl, Elisabeth
    Foley, Peter
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 329 - 335
  • [37] Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: An application in multiple sclerosis
    Friede, T.
    Parsons, N.
    Stallard, N.
    Todd, S.
    Marquez, E. Valdes
    Chataway, J.
    Nicholas, R.
    STATISTICS IN MEDICINE, 2011, 30 (13) : 1528 - 1540
  • [38] An R package for implementing simulations for seamless phase II/III clinical trials using early outcomes for treatment selection
    Parsons, Nick
    Friede, Tim
    Todd, Susan
    Marquez, Elsa Valdes
    Chataway, Jeremy
    Nicholas, Richard
    Stallard, Nigel
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2012, 56 (05) : 1150 - 1160
  • [39] Comparison of clinical outcomes following early rehabilitation in 3 cases of nephrotic syndrome with different treatment courses
    Kohji Iwai
    Yasuhiko Hatanaka
    Tamiro kawaguchi
    Shin-ich Araki
    CEN Case Reports, 2020, 9 : 365 - 369
  • [40] Comparison of clinical outcomes following early rehabilitation in 3 cases of nephrotic syndrome with different treatment courses
    Iwai, Kohji
    Hatanaka, Yasuhiko
    Kawaguchi, Tamiro
    Araki, Shin-ich
    CEN CASE REPORTS, 2020, 9 (04) : 365 - 369
12345